Cargando…

133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection

BACKGROUND: We recently developed a global respiratory severity score (GRSS) as a research tool from (n=139) infants with primary respiratory syncytial virus (RSV) infection enrolled prospectively in the Assessing Predictors of Infant RSV Effects and Severity (AsPIRES) study. The objective of the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Xing, Wang, Lu, Walsh, Edward E, Caserta, Mary T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777443/
http://dx.doi.org/10.1093/ofid/ofaa439.443
_version_ 1783630902925983744
author Qiu, Xing
Wang, Lu
Walsh, Edward E
Caserta, Mary T
author_facet Qiu, Xing
Wang, Lu
Walsh, Edward E
Caserta, Mary T
author_sort Qiu, Xing
collection PubMed
description BACKGROUND: We recently developed a global respiratory severity score (GRSS) as a research tool from (n=139) infants with primary respiratory syncytial virus (RSV) infection enrolled prospectively in the Assessing Predictors of Infant RSV Effects and Severity (AsPIRES) study. The objective of the present study was to validate our original findings that the GRSS correlates well with clinical outcomes including hospitalization and length of stay (LOS) utilizing an independent cohort. METHODS: Clinical and demographic data on infants with primary RSV infection were abstracted from the electronic medical record. The GRSS was calculated by applying the original training data formula to the new data set. We compared the mean GRSS between the hospitalized and non-hospitalized group with Welch two sample t-test, and correlated it with hospitalization and LOS using Pearson’s correlation test. RESULTS: A total of 184 (98 hospitalized and 86 non-hospitalized) subjects were enrolled. The hospitalized and non-hospitalized infants were different in general appearance, the percentage with rales, retractions, lethargy, respiratory rate and oxygen saturation. The hospitalized group had a significantly (t=9.334, p< 0.0001) higher GRSS (4.20±2.10) than the non-hospitalized group (1.76±1.41). Using GRSS ≤3.5 as the classification criterion, we correctly predicted the hospitalization status of 131 (71.2%) subjects. The area under the ROC curve of the GRSS as a classifier of hospitalization is AUC=0.8265 (p< 0.0001). Pearson correlation between the GRSS and LOS is (p< 0.0001). Area under the ROC curve of the GRSS [Image: see text] Boxplot demonstrating the difference in GRSS between hospitalized and non hospitalized infants [Image: see text] CONCLUSION: Infants hospitalized with RSV have a significantly higher GRSS than non-hospitalized subjects, and the GRSS is strongly associated with LOS. GRSS can also serve as an acceptable predictor of hospitalization. We are currently re-training the GRSS model with both datasets and believe it will lead to an improved predictive power of hospitalization. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777443
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77774432021-01-07 133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection Qiu, Xing Wang, Lu Walsh, Edward E Caserta, Mary T Open Forum Infect Dis Poster Abstracts BACKGROUND: We recently developed a global respiratory severity score (GRSS) as a research tool from (n=139) infants with primary respiratory syncytial virus (RSV) infection enrolled prospectively in the Assessing Predictors of Infant RSV Effects and Severity (AsPIRES) study. The objective of the present study was to validate our original findings that the GRSS correlates well with clinical outcomes including hospitalization and length of stay (LOS) utilizing an independent cohort. METHODS: Clinical and demographic data on infants with primary RSV infection were abstracted from the electronic medical record. The GRSS was calculated by applying the original training data formula to the new data set. We compared the mean GRSS between the hospitalized and non-hospitalized group with Welch two sample t-test, and correlated it with hospitalization and LOS using Pearson’s correlation test. RESULTS: A total of 184 (98 hospitalized and 86 non-hospitalized) subjects were enrolled. The hospitalized and non-hospitalized infants were different in general appearance, the percentage with rales, retractions, lethargy, respiratory rate and oxygen saturation. The hospitalized group had a significantly (t=9.334, p< 0.0001) higher GRSS (4.20±2.10) than the non-hospitalized group (1.76±1.41). Using GRSS ≤3.5 as the classification criterion, we correctly predicted the hospitalization status of 131 (71.2%) subjects. The area under the ROC curve of the GRSS as a classifier of hospitalization is AUC=0.8265 (p< 0.0001). Pearson correlation between the GRSS and LOS is (p< 0.0001). Area under the ROC curve of the GRSS [Image: see text] Boxplot demonstrating the difference in GRSS between hospitalized and non hospitalized infants [Image: see text] CONCLUSION: Infants hospitalized with RSV have a significantly higher GRSS than non-hospitalized subjects, and the GRSS is strongly associated with LOS. GRSS can also serve as an acceptable predictor of hospitalization. We are currently re-training the GRSS model with both datasets and believe it will lead to an improved predictive power of hospitalization. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777443/ http://dx.doi.org/10.1093/ofid/ofaa439.443 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Qiu, Xing
Wang, Lu
Walsh, Edward E
Caserta, Mary T
133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection
title 133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection
title_full 133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection
title_fullStr 133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection
title_full_unstemmed 133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection
title_short 133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection
title_sort 133. validation of a global respiratory severity score in infants with primary rsv infection
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777443/
http://dx.doi.org/10.1093/ofid/ofaa439.443
work_keys_str_mv AT qiuxing 133validationofaglobalrespiratoryseverityscoreininfantswithprimaryrsvinfection
AT wanglu 133validationofaglobalrespiratoryseverityscoreininfantswithprimaryrsvinfection
AT walshedwarde 133validationofaglobalrespiratoryseverityscoreininfantswithprimaryrsvinfection
AT casertamaryt 133validationofaglobalrespiratoryseverityscoreininfantswithprimaryrsvinfection